XML 50 R40.htm IDEA: XBRL DOCUMENT v3.4.0.3
Note 8 - Acquisition of EGEN, Inc. (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 02, 2016
Jun. 20, 2014
Jun. 10, 2014
Jun. 20, 2014
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Dec. 31, 2014
Jun. 09, 2014
EGEN Inc [Member] | Maximum [Member]                  
Business Combination, Consideration Transferred   $ 44,400,000              
EGEN Inc [Member] | Scenario, Forecast [Member]                  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares 670,070                
EGEN Inc [Member] | Ovarian Cancer Study Milestone [Member]                  
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 12,400,000                
EGEN Inc [Member] | Glioblastoma Multiforme Brain Cancer Study Milestone [Member]                  
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 12,000,000                
EGEN Inc [Member] | TheraSilence Technology Milestone [Member]                  
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 6,000,000                
EGEN Inc [Member] | Hercules Credit Agreement [Member]                  
Payments to Acquire Businesses, Gross     $ 3,000,000            
Loans Payable                 $ 5,000,000
EGEN Inc [Member] | In Process Research and Development [Member]                  
Finite-lived Intangible Assets Acquired   25,800,000              
EGEN Inc [Member]                  
Business Combination, Consideration Transferred   27,600,000   $ 27,578,000          
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High   30,400,000   $ 30,400,000 $ 30,400,000        
Payments to Acquire Businesses, Gross   $ 3,000,000              
Stock Issued During Period, Shares, Acquisitions   2,712,188   2,712,188 2,712,188        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares       670,070 670,070        
Business Combination, Consideration Transferred, Liabilities Incurred   $ 13,900,000   $ 13,878,000 $ 14,200,000 $ 13,800,000 $ 13,900,000 $ 13,700,000  
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability         302,656 172,136      
Goodwill, Acquired During Period   $ 2,000,000              
Business Combination, Consideration Transferred, Liabilities Incurred         $ 302,656 $ 13,800,000   $ 13,700,000